Start for free
Start for free
WuXi AppTec logo

WuXi AppTec

Asia, Shanghai, China, Shanghai

Description

WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.

Investor Profile

WuXi AppTec has made 31 investments, with 0 in the past 12 months and 16% as lead.

Stage Focus

  • Series B (35%)
  • Series A (35%)
  • Series C (10%)
  • Series D (6%)
  • Series Unknown (6%)
  • Series E (3%)
  • Seed (3%)

Country Focus

  • United States (55%)
  • China (32%)
  • Singapore (6%)
  • United Kingdom (3%)
  • Hong Kong (3%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Life Science
  • Therapeutics
  • Machine Learning
  • Artificial Intelligence (Ai)
  • Biopharma
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WuXi AppTec frequently co-invest with?

Pfizer Venture Investments
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 4
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 5
Google Ventures
Google Ventures
North America, California, United States, Mountain View
Co-Investments: 4
Partnership Fund for New York City
Partnership Fund for New York City
North America, New York, United States, New York
Co-Investments: 4
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 5
HongShan
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 5
6 Dimensions Capital
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 4
WF
Watson Fund
North America, Washington, United States, Seattle
Co-Investments: 5
Eli Lilly
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 5
ARCH Venture Partners
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 10

Which angels does WuXi AppTec often collaborate with?

HT
Henri Termeer
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
VW
Victor Wang
North America, Florida, United States, Miami Beach
Shared Deals: 1
JD
Jonathan Downey
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by WuXi AppTec?

D3 Bio

Shangai, Jiangxi, China

D3 Bio is a biotechnology company focusing on the development and registration of medicines.

BiotechnologyLife SciencePharmaceutical
Series AApr 8, 2024
Amount Raised: $62,000,000
Structure Therapeutics

South San Francisco, California, United States

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

BiotechnologyHealth CareMedicalPharmaceuticalProduct Research
Series BOct 20, 2021
Amount Raised: $100,000,000
Stemirna

Beijing, Beijing, China

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science.

BiotechnologyMedicalPharmaceutical
Series CJun 3, 2021
Amount Raised: $187,388,738
MegaRobo

Beijing, Beijing, China

MegaRobo is an AI and robotics company that specializes in the fields of life sciences, clinical diagnosis, and applied chemistry.

Artificial Intelligence (AI)BiotechnologyLife ScienceRobotics
Series UnknownMay 28, 2021
Amount Raised: $65,000,000
Engine Biosciences

Singapore, Central Region, Singapore

Engine Biosciences is a biotech company that applies machine learning to genomics for drug discovery.

Artificial Intelligence (AI)BiotechnologyHealth CareMachine Learning
Series AMay 26, 2021
Amount Raised: $43,000,000
AnchorDx

Guangzhou, Guangdong, China

AnchorDx is a precision medicine firm.

BiotechnologyEmergency MedicinePharmaceuticalPrecision Medicine
Series CFeb 22, 2021
Amount Raised: $40,000,000
JW Therapeutics

Shanghai, Shanghai, China

JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer treatment.

BiotechnologyHealth CareOncologyTherapeutics
Series BJun 11, 2020
Amount Raised: $100,000,000
Insitro

South San Francisco, California, United States

Insitro is a drug discovery and development startup that utilizes machine learning and biology to transform drug discovery.

BiotechnologyHealth CareLife ScienceMachine LearningPharmaceuticalTherapeutics
Series BMay 26, 2020
Amount Raised: $143,000,000
Immunocore

Abingdon, Oxfordshire, United Kingdom

Immunocore is a biotechnology company that specializes in the development of TCR bispecific immunotherapies.

BiotechnologyHealth CareMedicalPharmaceutical
Series BMar 2, 2020
Amount Raised: $130,000,000
CANbridge Pharmaceuticals

Beijing, Beijing, China

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

BiotechnologyHealth CarePharmaceutical
Series DFeb 18, 2020
Amount Raised: $98,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator